文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

多重耐药非伤寒沙门菌热点区可作为疫苗使用目标以管理地方性流行区感染

Multidrug-resistant Nontyphoidal Salmonella Hotspots as Targets for Vaccine Use in Management of Infections in Endemic Settings.
PubMed 文献 · Clin Infect Dis · 2019-01-01

在肯尼亚发热儿童中开展血培养及全基因组测序研究,共分析281株沙门菌。发现侵袭性非伤寒沙门菌多重耐药率为77.2%,其中15%对头孢曲松耐药。侵袭性非伤寒沙门菌与伤寒沙门菌聚集于公共售水点和污水汇流点附近,提示这些热点区可靶向引入伤寒和iNTS疫苗以降低传播。

要点

  • 侵袭性非伤寒沙门菌多重耐药率达77.2%,15%对头孢曲松耐药。
  • hotspots位于公共售水点和污水汇流点附近,可靶向干预。
  • 建议在热点区联合引入伤寒和iNTS疫苗以降低传播。

核心结论

  • 侵袭性非伤寒沙门菌多重耐药率高且部分对头孢曲松耐药,热点区可靶向疫苗控制。

研究设计与样本

  • 对发热儿童进行血培养,开展抗菌药物敏感性试验和全基因组测序,并用GPS映射病例家庭。
  • 共研究281株沙门菌,149株来自血液,132株来自粪便,均来自5岁以下发热儿童。

主要发现

  • 281株包括85株鼠伤寒沙门菌、58株肠炎沙门菌、32株其他NTS血清型和126株伤寒沙门菌。
  • 侵袭性NTS多重耐药率为77.2%,其中15%对头孢曲松耐药。
  • 侵袭性NTS和伤寒沙门菌共同映射在人口密集村的公共售水点和污水汇流点附近。

临床怎么用

  • 在地方性流行区可将疫苗引入重点瞄准侵袭性NTS和伤寒沙门菌聚集的热点区域。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Salmonella infections cause a disproportionately high number of deaths in Africa, especially among poor urban populations. The increasing level of multidrug-resistant (MDR) infections is a major cause of concern in these settings where alternative effective treatment is unavailable. Other options for management of these infections must be sought. The knowledge of hotspots in endemic settings can help to prioritize management and control measures in Kenya and the region. METHODS: Using blood cultures, we investigated children presenting with fever of unknown origin for Salmonella infections. We performed antimicrobial susceptibility testing and whole genome sequencing to further characterize Salmonella isolates. Using Global Positioning System technologies, we mapped Salmonella isolates to households of patients in the study site and determined risk factors associated with high concentration of cases in particular sites. RESULTS: A total of 281 Salmonella species (149 from blood and 132 from fecal samples) from febrile children <5 years of age were studied. These consisted of 85 Salmonella Typhimurium, 58 Salmonella Enteritidis, 32 other nontyphoidal Salmonella (NTS) serotypes, and 126 Salmonella Typhi. The prevalence of MDR invasive NTS (iNTS) was 77.2%, with 15% resistant to ceftriaxone, a drug that is last-line treatment for iNTS and other severe gram-negative infections in Kenya. Invasive NTS and S. Typhi together mapped around common water vending points and close to sewer convergence points in the highly populated village. CONCLUSIONS: These hotspots could be targeted for management and control strategies, including a combined introduction of typhoid and iNTS vaccines, aimed at reducing transmission in these endemic settings.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Kariuki S, Mbae C, Onsare R, et al. Multidrug-resistant Nontyphoidal Salmonella Hotspots as Targets for Vaccine Use in Management of Infections in Endemic Settings. Clin Infect Dis. 2019. PMID: 30767004. doi:10.1093/cid/ciy898

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。